Blog

Sun Pharma Q2 Results: Systematix Maintains ‘Buy’ Post Inline Performance — Check Target Price

Sun Pharma Q2 Review: A Detailed Analysis of the Company’s Performance Sun Pharmaceutical Industries Ltd. has announced its Q2 results, with revenues of Rs 144,783 million, growing by 8.9% year-over-year (YoY) and 4.5% quarter-over-quarter (QoQ). The results were in line with the estimates of Systematix and the consensus. The company’s India business, Emerging Markets, and

Blog

SBI Mutual Fund IPO: Details, Valuation, and Impact on Investors

SBI Mutual Fund IPO: A New Opportunity for Investors State Bank of India (SBI) is set to take its asset management arm public, with the executive committee of the lender’s board approving a partial divestment of its stake in SBI Funds Management Limited (SBIFML) through an Initial Public Offering (IPO). According to an exchange filing

Scroll to Top